We pursue a stage-agnostic investment strategy in healthcare, across multiple focus areas within the biopharmaceutical, medical device, diagnostic and healthcare technology sectors. Our venture activities span from very early stage opportunities, where great teams are addressing big problems, to small cap public companies with products in the clinic or close to the market, where we employ a value-driven approach. Our unified investment philosophy centers on helping great entrepreneurs and management teams deliver innovative new medicines, devices, diagnostics and solutions to the healthcare world.